Effect of Dietary Fat on the Testosterone (T) Pharmacokinetics (PK) of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men.

被引：0
|
作者：
Yin, A. [1 ,2 ]
Alfadhli, E. [1 ,2 ]
Htun, M. [1 ,2 ]
Dudley, R. E. [3 ]
Faulkner, S. [3 ]
Hull, L. [1 ,2 ]
Leung, A. [1 ,2 ]
Bross, R. [1 ,2 ]
Swerdloff, R. [1 ,2 ]
Wang, C. [1 ,2 ]
机构：
[1] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] Los Angeles BioMed Res Inst, Torrance, CA 90509 USA
[3] Clarus Therapeut Inc, Northbrook, IL USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ORAL TESTOSTERONE UNDECANOATE QUICKLY AND EFFECTIVELY ACHIEVES SERUM TESTOSTERONE ≥ 300 NG/DL IN MOST HYPOGONADAL MEN WITHOUT DOSE TITRATIONS
    Miner, M.
    Boldt-Houle, D. M.
    Atkinson, S. N.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [32] EFFECTS OF ORAL TESTOSTERONE UNDECANOATE ON SEMEN PARAMETERS IN HYPOGONADAL MEN: AN INTERIM ANALYSIS OF A PROSPECTIVE PILOT STUDY
    Saffati, G.
    Rendon, D. Orozco
    Kronstedt, S.
    Hinojosa-Gonzalez, D.
    Khera, M.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [33] EFFECTS OF AGE, BODY MASS INDEX (BMI) AND DIABETIC STATUS ON TESTOSTERONE LEVELS, TESTOSTERONE DOSING AND SAFETY IN HYPOGONADAL MEN TREATED WITH AN ORAL TESTOSTERONE UNDECANOATE (JATENZO)
    Honig, S.
    Swerdloff, R.
    Wang, C.
    Rohowsky, N.
    Newmark, J.
    Seo, B. W.
    Dudley, R.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [34] New testosterone buccal system (striant) delivers physiological testosterone levels: Pharmacokinetics study in hypogonadal men
    Wang, C
    Swerdloff, R
    Kipnes, M
    Matsumoto, AM
    Dobs, AS
    Cunningham, G
    Katznelson, L
    Weber, TJ
    Friedman, TC
    Snyder, P
    Levine, HL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3821 - 3829
  • [35] SIDE EFFECT PROFILE OF LONG-TERM TREATMENT OF ELDERLY HYPOGONADAL MEN WITH TESTOSTERONE UNDECANOATE
    Farid, S.
    Ahmad, H.
    Gheorghe, D.
    Louis, G.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 202 - 202
  • [36] SIDE EFFECT PROFILE OF LONG-TERM TREATMENT OF ELDERLY HYPOGONADAL MEN WITH TESTOSTERONE UNDECANOATE
    Saad, F.
    Doros, G.
    Haider, A.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 251 - 251
  • [37] ANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN - A DOUBLE-BLIND CONTROLLED-STUDY
    SKAKKEBAEK, NE
    BANCROFT, J
    DAVIDSON, DW
    WARNER, P
    CLINICAL ENDOCRINOLOGY, 1981, 14 (01) : 49 - 61
  • [38] BENEFICIAL EFFECTS OF LONG-TERM TESTOSTERONE REPLACEMENT THERAPY (TRT) WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD) IN AN OBSERVATIONAL REGISTRY STUDY
    Saad, F.
    Haider, A.
    Doros, G.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 12 - 13
  • [39] ERECTILE FUNCTION IN 656 HYPOGONADAL MEN: RESULTS OF LONG TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN COMPARISON WITH CONTROL GROUP
    Haider, Ahmad
    Haider, Karim
    Saad, Farid
    Doros, Gheorghe
    Traish, Abdulmaged
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1007 - E1007
  • [40] Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Type 2 Diabetes (T2DM) and Mortality in Hypogonadal Men
    Saad, Farid
    Haider, Ahmad
    Doros, Gheorghe
    Traish, Abdulmaged
    DIABETES, 2016, 65 : A271 - A271
12345